1. Alvira G, Hartzer M, Blumenkranz M, Camacho H (1989) Heparin, a possible new approach to the treatment of proliferative vitreoretinopathy. In: Heimann K, Wiedemann P (Hrsg) Proliferative Vitreoretinopathy. Kaden, Heidelberg, S 268–271.
2. Avery R, Glaser B (1986) Inhibition of retinal pigment epithelial cell attachment by a synthetic peptide drived from the cell binding domain of fibronectin. Arch Opthalmol 104: 1220–1222.
3. Berman DH, Gombos GM (1989) Proliferative vitreoretinopathy: does oral low-dose colchicme have an inhibitory effect? A controlled study in humans. Ophthalmic Surg 20: 268–272.
4. Blumenkranz M, Hernandez E, Ophir A und Norton EW (1984). “5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite.” Ophthalmoloogy. 921(2):122–130.
5. Bonnet M (1989). Clinical findings associated with the development of postoperative PVR in primary rhegmatogenous retinal detachment. In Heimann K, Wiedemann P (Hrsg) Proliferative Vitreoretinopathy. Kaden, Heidelberg, S 18–20.